Laryngeal cancer secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Laryngeal cancer}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WikiDoc Help Menu}} {{WikiDoc Sources}} Category:Disease Category:Oncology [[Category:Type...")
 
No edit summary
 
(5 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
{{Laryngeal cancer}}
{{Laryngeal cancer}}
{{CMG}}
{{CMG}} {{AE}}{{Faizan}}
==Overview==
[[Secondary prevention]] measures of [[laryngeal cancer]] include routine [[physical examination]] and [[imaging]] at scheduled intervals after treatment. [[Dental]] [[screening]] and [[screening]] for [[thyroid cancers]] are recommended among [[patients]] who had received [[radiation therapy]] to the [[oral cavity]] and [[cervical]] region, respectively.


==Overview==
==Secondary Prevention==
===Follow up after treatment===
Patients treated for [[laryngeal carcinoma]] should follow-up for [[secondary prevention]]. Follow-up measures are shown in the table below:<ref name="pmid23946171">{{cite journal| author=Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ et al.| title=Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 8 | pages= 917-23 | pmid=23946171 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23946171  }} </ref>
 
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
| valign="top" |
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Follow up}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Description}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:Physical exam
| style="padding: 5px 5px; background: #F5F5F5;" |
*Every 1-3 months during the 1st year after treatment
*Every 2-6 months during the 2nd year after treatment
*Every 4-8 months between the 3rd and 5th years after treatment
*Annually thereafter
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Nasendoscopy
| style="padding: 5px 5px; background: #F5F5F5;" |
*Immediately following [[radiation therapy]]
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:CT Scan/MRI
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Imaging]] studies are performed at routine intervals as follows:
:*Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of [[physical exam]] and [[Symptom|symptoms]] experienced by the patient
:*Scanning for asymptomatic [[patients]] is not recommended
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Thyroid hormone testing
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Thyroid-stimulating hormone|Thyroid stimulating hormone]] testing every 12 months if the [[neck]] was exposed to [[radiation]]
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Dental screening
| style="padding: 5px 5px; background: #F5F5F5;" |
*Only recommended if [[oral cavity]] was exposed to [[radiation]]
|-
|}


==References==
==References==
Line 11: Line 54:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Types of cancer]]
[[Category:Medicine]]
[[Category:Otolaryngology]]

Latest revision as of 00:47, 20 March 2019

Laryngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Laryngeal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal cancer secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal cancer secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal cancer secondary prevention

CDC on Laryngeal cancer secondary prevention

Laryngeal cancer secondary prevention in the news

Blogs on Laryngeal cancer secondary prevention

Directions to Hospitals Treating Laryngeal cancer

Risk calculators and risk factors for Laryngeal cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Secondary prevention measures of laryngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.

Secondary Prevention

Follow up after treatment

Patients treated for laryngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1]

Follow up Description
Physical exam
  • Every 1-3 months during the 1st year after treatment
  • Every 2-6 months during the 2nd year after treatment
  • Every 4-8 months between the 3rd and 5th years after treatment
  • Annually thereafter
Nasendoscopy
CT Scan/MRI
  • Imaging studies are performed at routine intervals as follows:
  • Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient
  • Scanning for asymptomatic patients is not recommended
Thyroid hormone testing
Dental screening

References

  1. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.


Template:WikiDoc Sources